(Q45973048)

18 December 2017

title

Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. (English)

1 reference

18 December 2017

1 reference

1 reference

Ambra Pozzi

1

1 reference

18 December 2017

Wendy F LeVine

series ordinal

2

1 reference

18 December 2017

Humphrey A Gardner

series ordinal

3

1 reference

18 December 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

18 December 2017

published in

Oncogene

1 reference

18 December 2017

volume

21

1 reference

18 December 2017

page(s)

272-281

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205045

exact match

0 references

cites work

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Tetracycline derivatives induce apoptosis selectively in cultured monocytes and macrophages but not in mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Matrix metalloproteinases and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

MMP inhibition in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Integrin alpha1beta1 mediates a unique collagen-dependent proliferation pathway in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Inhibition of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Isolation and characterization of the circulating form of human endostatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

The antitumour effect of doxycycline on a T-cell leukaemia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

Simple and reliable method of doxycycline determination in human plasma and biological tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Effects of doxycycline on cancer cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Suppression of human microvascular endothelial cell invasion and morphogenesis with synthetic matrixin inhibitors. Targeting angiogenesis with MMP inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Inhibition of matrix metalloproteinase 9 activation by a specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Complex role of matrix metalloproteinases in angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205045

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205045

1 reference

18 December 2017

Dimensions Publication ID

0 references

1 reference

18 December 2017